FDA Drug Shortages (New and Updated) - September 6, 2022

U.S. Food and Drug Administration sent this bulletin at 09/07/2022 06:36 AM EDT

If your email program has trouble displaying this email, view as a webpage.

Thank you for subscribing to our newsletter. In an effort to consolidate information and effectively communicate with you, this newsletter will be eliminated after Sept. 30, 2022. As a result, you will find this information in the CDER New bulletin (example from July 21, 2022).

Subscribe to CDER New bulletin

Drug Shortages

FDA Drug Shortages
- Amino Acids (Updated - Currently in Shortage)
- Amoxapine Tablets (Updated - Currently in Shortage)
- Azacitidine for Injection (Updated - Currently in Shortage)
- Dextrose 10% Injection (Updated - Currently in Shortage)
- Dextrose 5% Injection (Updated - Currently in Shortage)
- Diflunisal Tablets (Updated - Currently in Shortage)
- Disopyramide Phosphate (Norpace) Capsules (Updated - Currently in Shortage)
- Epinephrine Injection, Auto-Injector (Updated - Currently in Shortage)
- Fludarabine Phosphate Injection (Updated - Currently in Shortage)
- Fluvoxamine ER Capsules (Updated - Currently in Shortage)
- Glyburide and Metformin Hydrochloride Tablets (New - Discontinuation)
- Guanfacine Hydrochloride Tablets (Updated - Currently in Shortage)
- Hydromorphone Hydrochloride Injection (Updated - Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection (New - Currently in Shortage)
- Nizatidine Capsules (Updated - Currently in Shortage)
- Propofol Injectable Emulsion (Updated - Currently in Shortage)
- Sodium Chloride 0.9% Injection Bags (Updated - Currently in Shortage)
- Streptozocin (Zanosar) Sterile Powder (Updated - Currently in Shortage)
- Sulfasalazine Tablets (Updated - Currently in Shortage)

Manage Subscriptions | Unsubscribe All | Help